Enzyme-linked immunosorbent assays for the synthetic steroid Gestrinone (cas 16320-04-0)
-
Add time:08/02/2019 Source:sciencedirect.com
Gestrinone is a synthetic steroid hormone with anti-estrogenic and anti-progesterone properties. It is used to treat endometriosis, shrink uterine fibroids and reduce menorrhagia; besides, it has been investigated for use as contraceptive. Also, due to its anabolic effects, it has been included in the banned list of performance enhanced drugs in sport. Polyclonal antibodies raised against bovine serum albumin coupled to gestrinone 3-carboxymethyloxime (3OCMO-G) were used to develop two highly sensitive and specific enzyme-linked immunosorbent assays for gestrinone. One of them, based on direct format, shows a detection limit (LD) of 0.09 ± 0.03 ng L−1. The second assay, hapten-protein coating format, can detect until (LD) 0.14 ± 0.05 ng L−1. Both immunoassays were also highly specific, showing negligible or no cross-reactivity to other anabolic steroids. The developed ELISAs detected lower amounts of gestrinone than those determined by the reference chromatographic HPLC/MS/MS methods. The direct format was applied to quantify this steroid in spiked human urine without sample pre-treatment, with recovery values between 76 and 122%.
We also recommend Trading Suppliers and Manufacturers of Gestrinone (cas 16320-04-0). Pls Click Website Link as below: cas 16320-04-0 suppliers
Prev:Modified steroid hormones—XXXVI
Next:Mechanism of emergency contraception with Gestrinone (cas 16320-04-0): a preliminary investigation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Endometrial patterns during therapy with danazol or Gestrinone (cas 16320-04-0) for endometriosis: Structural and ultrastructural study08/09/2019
- Individual and combined effects of triptoreline and Gestrinone (cas 16320-04-0) on experimental endometriosis in rats08/08/2019
- Gestrinone (cas 16320-04-0) inhibits macrophage function and mitogen-stimulated lymphocyte proliferation in vitro08/07/2019
- Gestrinone (cas 16320-04-0) versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study*08/06/2019
- Gestrinone (cas 16320-04-0) versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation08/05/2019
- Gestrinone (cas 16320-04-0) inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK08/04/2019
- Mechanism of emergency contraception with Gestrinone (cas 16320-04-0): a preliminary investigation08/03/2019


